Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Prostatic Neoplasms 1 Pelvic Neoplasms 1 Osteosarcoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1

Interventions

X-Rays 8 Specimen Handling 8 Cyclophosphamide 8 Phantoms, Imaging 7 Magnetic Resonance Spectroscopy 6 fludarabine 5 cabozantinib 5 Gemcitabine 5 Biopsy 5 Nuclear Medicine Department, Hospital 4 Methotrexate 4 Doxorubicin 4 fludarabine phosphate 3 Ifosfamide 3 Cisplatin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 pembrolizumab 2 palbociclib 2 olaparib 2 mifamurtide 2 larotrectinib 2 ivosidenib 2 irinotecan sucrosofate 2 ensartinib 2 atezolizumab 2 Vincristine 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Pafolacianine × 90 days × Clear all

NCT06235125 2026-06-05

Cytalux

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 1 Recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡